20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters-Reference-Cited by-同舟云学术

20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters

Published:2011-08-31 Issue:2 Volume:19 Page:627-635
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Deroose Jan P.,Eggermont Alexander M. M.,van Geel Albertus N.,de Wilt Johannes H. W.,Burger Jacobus W. A.,Verhoef Cornelis

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-011-2030-7

Reference47 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

2. Jaques DP, Coit DG, Brennan MF. Major amputation for advanced malignant melanoma. Surg Gynecol Obstet. 1989;169:1–6.

3. Karakousis CP, Choe KJ, Holyoke ED. Biologic behavior and treatment of intransit metastasis of melanoma. Surg Gynecol Obstet. 1980;150:29–32.

4. Creech O, Jr., Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg. 1958;148:616–32.

5. Benckhuijsen C, Kroon BB, van Geel AN, Wieberdink J. Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics. Eur J Surg Oncol. 1988;14:157–63.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Technical considerations for isolated limb perfusion: A consensus paper;European Journal of Surgical Oncology;2024-06

2. Isolated Limb Perfusion for Extremity Soft Tissue Sarcoma and Malignant Melanoma;Indian Journal of Surgical Oncology;2024-04-08

3. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022;European Journal of Cancer;2022-07

4. Isolated limb perfusion for locally advanced melanoma in the immunotherapy era;European Journal of Surgical Oncology;2022-06

5. Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities;Cancers;2021-10-31